Other diseases
Niemann–Pick disease type C
尼曼-匹克病 C 型
An inherited disorder of intracellular lipid transport that can affect the liver, spleen and nervous system.
Definition adapted from MeSH (US National Library of Medicine)
- hospitals in mainland China
- 15
- cities
- 11
- open trials in China
- 0
with a paper from 2016–2025 or a registered study
where those hospitals are
ClinicalTrials.gov, 13 Nov 2026
Mainland China accounts for 6% of the world's English-language research papers on Niemann–Pick disease type C, 2021–2025 (4% in 2016–2020), and 5% of the world's registered trials on it have a site in China.
Research activity in public records, not a rating of care and not medical advice. How the numbers are made
15 hospitals in 11 cities
Order: papers led on Niemann–Pick disease type C, 2021–2025, then A–Z. Research activity, not a rating of care.
A hospital is listed when it led at least 1 papers or 1 trial on Niemann–Pick disease type C, or was a site in 1 or more trials. “Papers led” counts English-language PubMed papers whose first or last author lists the hospital first. Hospitals not listed may also treat it. Definitions
Cities with the most listed hospitals
Each opens Niemann–Pick disease type C in that city. 1 more cities are in the menu below.
- 1 paper ledNo open trial led
- 1 paper ledNo open trial led
- 1 paper ledNo open trial led
- 1 paper ledNo open trial led
- 1 paper ledNo open trial led
- 1 paper ledNo open trial led
- 1 paper ledNo open trial led
- 0 papers ledNo open trial led
- 0 papers ledNo open trial led
- 0 papers ledNo open trial led
- 0 papers ledNo open trial led
- 0 papers ledNo open trial led
- 0 papers ledNo open trial led
- 0 papers ledNo open trial led
- 0 papers ledNo open trial led
No listed hospital matches these filters.
By university or health system 1
Hospitals carrying a university’s name, added together, plus papers that name only the university. Same order as above.
- 1 paper led1 hospital
0
open trials on Niemann–Pick disease type C in China
Recruiting, not yet recruiting, or by invitation, as registered on ClinicalTrials.gov on 13 Nov 2026, with at least one listed hospital as lead sponsor or site, and at least one listed hospital's site marked open. Check the registry for the current status. Whether someone can take part is decided by the study team.
Trials registered only in China’s own registry (ChiCTR) are not included. Questions to check before asking about a trial
Before contacting a hospital
The same for every disease, so it is kept on one page. Each hospital page also has an enquiry letter in English and Chinese, and a name card to show staff.
- How to startTalk with the treating doctor, prepare the records hospitals ask for, then write to two or three hospitals.
- Questions to check before asking about a trialWhat the registered criteria usually ask about, and what to ask the study team.
- Common questionsInternational patients, costs, trials and visas.
Where these numbers come from
Papers
16 English-language PubMed papers on Niemann–Pick disease type C with an author in mainland China, 2021–2025; a hospital led a paper when its first or last author lists it first. Run the PubMed search
Trials
ClinicalTrials.gov records with a listed hospital as lead sponsor or site, as of 13 Nov 2026. ChiCTR is not included. Search ClinicalTrials.gov
Locations
Locations are shown at city centres. Check the hospital’s website for its address.